Know Cancer

or
forgot password

Communication Skills Intervention to Promote Transition Into Survivorship


N/A
18 Years
N/A
Open (Enrolling)
Both
Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma

Thank you

Trial Information

Communication Skills Intervention to Promote Transition Into Survivorship


Inclusion Criteria:



Physicians:

- who treat patients with DLBCL and HD as per self report

Patients of Physicians:

- have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology
report or physician assessment in medical record and/or clinical judgment of the
treating physician treated with curative intent.

For part 1 - have scans indicating remission and completing planned chemotherapy and/or
radiation therapy. The treating physician will determine that clinical remission has been
achieved based on their best judgment.

For part 2 (longitudinal phase): - have new scans indicating remission and completing
planned chemotherapy and/or radiation therapy. The treating physician will determine that
clinical remission has been achieved based on their best judgment.

- be at least 18 years old

- speak English well enough, in the judgment of the consenting professional, to be able
to understand all aspects of the study, provide informed consent, and be able to
complete all study measures.

Exclusion Criteria:

Physicians:

- who do not have adequate patients in their clinical practice to meet the 8 patient
enrollment requirement for patients with either DLBCL or HD as per self report

Patients of Physicians:

- show evidence of cognitive impairment severe enough to preclude giving permission to
the study staff, or completing the survey instruments of the study.

- as per physician judgment, patient's prognosis and/or co-morbidities make them
inappropriate for participation in a survivorship study.

For Part 2 ONLY (longitudinal phase):

- those who consented to part 1, consult recording, of the study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

impact on patient outcomes of targeted physician communication skills training

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Steven Horwitz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

11-180

NCT ID:

NCT01483664

Start Date:

November 2011

Completion Date:

November 2014

Related Keywords:

  • Hodgkin's Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • patient outcomes
  • Survivorship
  • Communication Skills
  • Communication strategies
  • Physicians communication
  • 11-180
  • Hodgkin Disease
  • Lymphoma
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse

Name

Location

MD Anderson Cancer CenterHouston, Texas  77030-4096
Memorial Sloan-Kettering Cancer CenterNew York, New York  10021
Maimonides Medical CenterBrooklyn, New York  11219
Moffitt Cancer CenterTampa, Florida  33612